Lymphoma Conference. Rome, March rd POSTGRADUATE. VOI Donna Camilla Savelli Hotel. Scientific Committee: Presidents:
|
|
- Phillip Mills
- 6 years ago
- Views:
Transcription
1 3 rd POSTGRADUATE Lymphoma Conference Rome, March VOI Donna Camilla Savelli Hotel Presidents: A.M. Carella P.L. Zinzani Scientific Committee: A.M. Carella B.D. Cheson S.A. Pileri A. Younes P.L. Zinzani
2 Rome, March Ranjana Advani Stanford, USA Stephen M. Ansell Rochester, USA Christian Buske Ulm, Germany Angelo Michele Carella Genoa, Italy Jorge J. Castillo Boston, USA Robert Chen Duarte, USA Selina Chen-Kiang New York, USA Bruce D. Cheson Washington, USA Andrew Davies Southamtpon, United Kingdom Martin Dreyling Munich, Germany John F. Gerecitano New York, USA Olivier Hermine Paris, France Georg Hess Mainz, Germany Wojciech Jurczak Kraków, Poland Steven Le Gouill Nantes, France Brian Link Iowa City, USA Peter Martin New York, USA Ari M. Melnick New York, USA Craig H. Moskowitz New York, USA Owen A. O Connor New York, USA Stefano A. Pileri Milan, Italy Simon Rule Plymouth, United Kingdom Alexandra Traverse-Glehen Lyon, France Wyndham H. Wilson Bethesda, USA Anas Younes New York, USA Pier Luigi Zinzani Bologna, Italy
3 Thursday, March 23, am Welcome and Introduction A.M. Carella, P.L. Zinzani Session I Chairmen: M. Dreyling, P. Martin 8.45 am New research issues S. Chen-Kiang 9.00 am General discussion 9.15 am Front-line treatment in young patients: European perspective M. Dreyling American perspective P. Martin Role of maintenance therapy S. Le Gouill am General discussion am Round Table - Relapsed/refractory setting: Lenalidomide P. Martin Temsirolimus G. Hess Bortezomib O.A. O Connor Ibrutinib M. Dreyling Allotransplant O. Hermine am General discussion am Coffee break pm Newer agents: Acalabrutinib S. Rule Venetoclax S. Le Gouill Palbociclib P. Martin BGB-3111 S. Rule 1.00 pm General discussion 1.15 pm Lunch Session II Hodgkin Lymphoma Chairman: A. Younes Relapsed/refractory setting: 2.30 pm Brentuximab Vedotin A. Younes 2.45 pm General discussion 3.00 pm Nivolumab S.M. Ansell 3.15 pm General discussion 3.30 pm Pembrolizumab R. Chen 3.45 pm General discussion 4.00 pm Response criteria on checkpoint inhibitors treatment B.D. Cheson 4.15 pm General discussion 4.30 pm Autotransplant and beyond C.H. Moskowitz 4.45 pm General discussion 5.00 pm Issues for the Round Table - all speakers: Treatment choice for CRs during checkpoint inhibitors Checkpoint inhibitors post allotransplant Brentuximab Vedotin and checkpoint inhibitors in front-line setting 5.45 pm General discussion 2 Hodgkin Lymphoma 3 Hodgkin Lymphoma
4 Friday, March 24, am LECTURE News on T-cell lymphoma drugs R. Advani 8.20 am General discussion Session III Chairman: B.D. Cheson 8.30 am WHO news S.A. Pileri 8.45 am General discussion 9.00 am Epigenetic news in follicular lymphoma A.M. Melnick 9.15 am General discussion 9.30 am Transformed follicular lymphoma: biology and treatment B.L. Link 9.45 am General discussion am New biological agents (single agent and combo): PI3K inhibitors A. Younes BTK inhibitors B.D. Cheson BCL-2 inhibitors J. Gerecitano Session IV Diffuse Large B-Cell Lymphoma Chairman: A.M. Carella 1.00 pm Debate - Primary mediastinal lymphoma: R-DA-EPOCH W. Wilson I-II-III generation chemotherapy regimens A. Davies 1.30 pm General discussion 1.45 pm Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas: Molecular data A. Traverse-Glehen Clinical presentation B.L. Link 2.15 pm General discussion 2.30 pm Plasmoblastic lymphoma J.J. Castillo 2.45 pm General discussion 3.00 pm New agents S.M. Ansell 3.15 pm General discussion 3.30 pm Arrivederci A.M. Carella, P.L. Zinzani am General discussion am New anti-cd20 monoclonal antibodies C. Buske am General discussion am Biosimilar rituximab W. Jurczak am General discussion pm Lunch Diffuse Large B-Cell Lymphoma 4 5 Diffuse Large B-Cell Lymphoma
5 With an unrestricted educational grant of: GENERAL INFORMATION Meeting Venue VOI Donna Camilla Savelli Hotel Via Garibaldi, Rome, Italy Phone: Official Language English. Slides Slides must be in English. Computer videoprojection will be available in Power Point. Other requirements should be communicated to the Organizing Secretariat as soon as possible. Slides should be handed to the slide center one hour before the beginning of the session and collected at the end. Badge All registered participants and speakers will be given a badge which they must wear to be admitted to the scientific sessions. Attendance certificate A certificate will be given to all participants at the end of the meeting. CME An application for Italian CME credits have been made as follows: - Provider Studio ER Congressi SRL: ID No. 15,1 CME credits for physicians (disciplines: Hematology, Oncology, Radiotherapy). - Educational objective: guidelines-protocols-procedures. Changes Parts of the program may be changed without notice. Organizing Secretariat Studio E.R. Congressi Via Marconi, Bologna Phone: Fax: ercongressi@ercongressi.it
New Drugs in Hematology
New Drugs in Hematology Bologna, Royal Hotel Carlton, May 9-11, 2016 PROGRAM Monday, May 9, 2016 9.00 am Welcome and Introduction Three recent impressive stories Chairman: F. Pane 9.15 am Brentuximab vedotin
More informationHematologic diseases in the elderly. Promoted by. Organized by Institute of Hematology L. e A. Seràgnoli University of Bologna
Promoted by Presidents Prof. P.L. Zinzani, Bologna (Italy) Prof. L. Balducci, Tampa FL (US) Organized by Institute of Hematology L. e A. Seràgnoli University of Bologna Under the Patronage of SIE - Società
More informationEmerging targeted therapies for follicular lymphoma A future without chemotherapy
Emerging targeted therapies for follicular lymphoma A future without chemotherapy Pier Luigi Zinzani Institute of Hematology L. e A. Seràgnoli University of Bologna FOLLICULAR LYMPHOMA: GENERAL ASPECTS
More information13-ICML SATELLITE SYMPOSIA PROGRAMS (updated on May 9, 2015)
Hematological Oncology Hematol Oncol 2015; 33: 333 344 Published online in Wiley Online Library (wileyonlinelibrary.com).2231 Supplement Article 13-ICML SATELLITE SYMPOSIA PROGRAMS (updated on May 9, 2015)
More informationPembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Phase 2 KEYNOTE-087 Study
Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Phase 2 KEYNOTE-087 Study Craig H. Moskowitz, 1 Pier Luigi Zinzani, 2 Michelle A. Fanale, 3 Philippe Armand, 4 Nathalie Johnson, 5 John
More informationOctober 17 20, 2018 New York City. An International Congress on Lymphoma, Myeloma, and Leukemia Disorders
An International Congress on Lymphoma, Myeloma, and Leukemia Disorders NEW DAY! New Approaches in Acute Leukemias and Hematologic Malignancies Wednesday, October 17 October 17 20, 2018 New York City lymphomaandmyeloma.com
More informationInternational Symposium on: NEW TRENDS IN DIABETES AND OBESITY TREATMENT
Congress Center S. Domenico Palace Taormina, Sicily (Italy) - October 6-8, 2016 International Symposium on: NEW TRENDS IN DIABETES AND OBESITY TREATMENT Organized by Endocrinology, Department of Clinical
More informationPresented at the 59th American Society of Hematology (ASH) Annual Meeting & Exposition; December 9 12, 2017; Atlanta, GA, USA
65 Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 25 Study Jonathon B. Cohen, 1 Andreas
More informationBOLZANO March 21-23, 2019
BOLZANO March 21-23, 2019 Parkhotel Laurin Under the auspices of OrganizATION AND COMMITTE Scientific DIRECTOR Prof. Christian Dejaco Rheumatology Unit Azienda Sanitaria Alto Adige Hospital Brunico-Bruneck
More informationPULMONARY HYPERTENSION. by CLINICAL CASES. An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
Under the Aegis of PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases BOLOGNA June 28-29, 2013 Palazzo dell Archiginnasio
More informationAGRESSIVE LYMPHOMAS - FUTURE. Dr Stéphane Doucet CHUM
AGRESSIVE LYMPHOMAS - FUTURE Dr Stéphane Doucet CHUM What are clinical trials? Clinical trials are carefully planned research studies where the most-promising discoveries and results from laboratory studies
More informationPULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace
Under the Aegis of European Board for Accreditation in Cardiology PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
More information*Jagiellonian University, Kraków, Poland
Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin s Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study Wojciech Jurczak, *
More informationHodgkin Lymphoma Nivolumab
New Drugs In Hematology Hodgkin Lymphoma Nivolumab Anas Younes, M.D. Chief, Lymphoma Service Memorial Sloan-Kettering Cancer Center Monday, May 9, 2016 2:10-2:25 p.m immunotherapy modalities CAR T Cells
More informationSYMPOSIUM ON LYMPHOMA
4th ANNUAL MSK SYMPOSIUM ON LYMPHOMA State-of-the-Art in Biology, Therapy, and Patient Care MAY 10-11, 2019 Memorial Sloan Kettering Cancer Center Zuckerman Research Center New York, NY 4 th Annual MSK
More informationFEBRUARY 17 TH. NAPLES Hotel Royal Continental. Director: Fortunato Ciardiello 6.6 CME Credits
FEBRUARY 17 TH 2017 NAPLES Hotel Royal Continental Director: 6.6 CME Credits Addressed to The meeting is addressed to oncologists specialized in colorectal cancer. Objectives The therapeutical choice for
More informationPatronage requested A. ANICHINI (MILAN, ITALY) L. CERCHIETTI (NEW YORK, USA) M.P. COLOMBO (MILAN, ITALY) P. CORRADINI (MILAN, ITALY)
Patronage requested Faculty A. ANICHINI (MILAN, ITALY) L. CERCHIETTI (NEW YORK, USA) M.P. COLOMBO (MILAN, ITALY) P. CORRADINI (MILAN, ITALY) F. DE BRAUD (MILAN, ITALY) M. DEL VECCHIO (MILAN, ITALY) M.
More informationHodgkin Lymphoma New Combo-Steps
New Drugs In Hematology Hodgkin Lymphoma New Combo-Steps Anas Younes, M.D. Chief, Lymphoma Service Memorial Sloan-Kettering Cancer Center Monday, May 9, 2016 2:55-3:10 p.m Combinations with Immune Checkpoint
More informationKamakshi V Rao, PharmD, BCOP, FASHP University of North Carolina Medical Center UPDATE IN REFRACTORY HODGKIN LYMPHOMA
Kamakshi V Rao, PharmD, BCOP, FASHP University of North Carolina Medical Center UPDATE IN REFRACTORY HODGKIN LYMPHOMA Objectives Describe the current standard approach for patients with relapsed/refractory
More informationMechanical Ventilation KRAKOW POLAND NOVEMBER 29-30, 2018
on Mechanical Ventilation KRAKOW POLAND NOVEMBER 29-30, 2018 KRAKOW POLAND NOVEMBER 29-30, 2018 The SMART COURSE on Mechanical Ventilation features a highly interactive program, aimed at melting speakers
More informationAggressive lymphomas ASH Dr. A. Van Hoof A.Z. St.Jan, Brugge-Oostende AV
Aggressive lymphomas ASH 2015 Dr. A. Van Hoof A.Z. St.Jan, Brugge-Oostende AV CHOP 1992 2002 R-CHOP For DLBCL High dose chemo With PBSCT Aggressive lymphomas 1.DLBCL 2.Primary Mediastinal Lymphoma 3.CNS
More informationPRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Nice, France
PRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Live educational course dates The live educational course H&N Preceptorship: Focus on comprehensive management" will be held on
More informationFriday, May 18 SESSION Opening remarks L. Bolondi - Bologna (Italy)
Friday, May 18 09.00 Opening remarks L. Bolondi - Bologna (Italy) SESSION 1 THE ROLE OF CIRCULATING AND TISSUE BIOMARKERS Chair: J.C. Nault - Paris (France) 09.10 Predicting the development of HCC in liver
More information12 th EMN Annual Meeting Euroacademia Multidisciplinaria Neurotraumatologica
12 th EMN Annual Meeting Euroacademia Multidisciplinaria Neurotraumatologica Roma (Italy), June 21-23, 2007 Pre-Meeting of the 56 Congresso Nazionale SINch Società Italiana di Neurochirurgia Joint Meeting
More informationINTERNATIONAL MEETING SPONDYLOSIS and SPONDYLITIS
FINAL PROGRAM INTERNATIONAL MEETING SPONDYLOSIS and SPONDYLITIS NEW ASPECTS IN THE SURGICAL TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISORDERS OF THE SPINE Organized by the Neurosurgery Unit of Pisa
More informationMantle cell lymphoma Allo stem cell transplantation in relapsed and refractory patients
Mantle cell lymphoma Allo stem cell transplantation in relapsed and refractory patients Olivier Hermine MD, PhD Department of Hematology INSERM and CNRS, Imagine Institute Necker Hospital Paris, France
More informationLIQUID BIOPSY: TRACKING CANCER
A.R.Ger.On ONLUS SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 prog ram Pierre-Auguste Renoir Chemin montant dans les hautes herbes SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER President Paola
More informationHodgkin Lymphoma. Barbara Pro, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois
Hodgkin Lymphoma Barbara Pro, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois Hodgkin Lymphoma Successes and Challenges The success 80 % of patients achieve
More informationFIRST INTERNATIONAL PADUA MEETING ON SEVERE BLEEDING MANAGEMENT
FIRST INTERNATIONAL PADUA MEETING ON SEVERE BLEEDING MANAGEMENT PADUA 12 th November 2013 Aula Morgagni Policlinico Universitario Chief: Prof. Paolo Simioni Department of Cardiologic, Thoracic and Vascular
More informationEDUCATIONAL COURSE. MUSCULOSKELETAL ULTRASOUND in RHEUMATOLOGY BASIC COURSE. Course Coordinator Annamaria Iagnocco
EDUCATIONAL COURSE 2019 MUSCULOSKELETAL ULTRASOUND in RHEUMATOLOGY BASIC COURSE Rome, March 21-23, 2019 Course Coordinator Annamaria Iagnocco COURSE PRESENTATION Musculoskeletal ultrasound in rheumatology
More informationImmune checkpoint inhibitors in Hodgkin and non-hodgkin Lymphoma: How do they work? Where will we use them? Stephen M. Ansell, MD, PhD Mayo Clinic
Immune checkpoint inhibitors in Hodgkin and non-hodgkin Lymphoma: How do they work? Where will we use them? Stephen M. Ansell, MD, PhD Mayo Clinic Conflicts of Interest Research Funding from Bristol Myers
More informationLymphoma- Med A-new drugs and treatments
Lymphoma- Med A-new drugs and treatments Silvia Montoto Lisbon, 19/03/2018 #EBMT18 www.ebmt.or Disclosures: Roche, Gilead Silvia Montoto Lisbon, 19/03/2018 #EBMT18 www.ebmt.or Outline Lymphoma- what is
More informationClinical Trial News on the Treatment of Waldenstrom s Macroglobulinemia
Clinical Trial News on the Treatment of Waldenstrom s Macroglobulinemia Edward Libby M.D. Associate Professor, University of Washington Department of Medicine, Division of Medical Oncology Fred Hutchinson
More informationJune 4 th - 6 th 2014 Milazzo, Italy. 3 rd Workshop on Synaptic Plasticity: from bench to bedside
June 4 th - 6 th 2014 Milazzo, Italy 3 rd Workshop on Synaptic Plasticity: from bench to bedside WELCOME Dear Colleagues and Friends, We welcome you to the 3rd Workshop on Synaptic Plasticity: from bench
More informationTwo Decades of Sagittal Balance. Meet The Experts 2018 Meeting. Meliá Castilla Madrid - Spain. 16 & 17 March 2018
Meet The Experts 2018 Meeting Spine Sciences Forum - Meet the Experts Two Decades of Sagittal Balance 16 & 17 March 2018 Meliá Castilla Madrid - Spain Faculty Welcome Address Chairmen Max Aebi Pedro Berjano
More informationKTE-C19 for relapsed or refractory mantle cell lymphoma
NIHR Innovation Observatory Evidence Briefing: July 2017 KTE-C19 for relapsed or refractory mantle cell lymphoma NIHRIO (HSRIC) ID: 11846 NICE ID: 9122 LAY SUMMARY Mantle cell lymphoma is an uncommon type
More informationKEEPING MEN HEALTHY: LET'S ASSEMBLE THE PUZZLE
International Symposium on: KEEPING MEN HEALTHY: LET'S ASSEMBLE THE PUZZLE Evidence from basic, traslational and clinical research Naples (Italy), June 19 th -20 th, 2015 Organized by DEPARTMENT OF PHARMACOLOGY
More informationTreatment Approaches in Relapsed/Refractory HL. Brentuximab Vedo=n. Anas Younes, M.D. Chief, Lymphoma Service Memorial Sloan-Ke=ering Cancer Center
Treatment Approaches in Relapsed/Refractory HL Brentuximab Vedo=n Anas Younes, M.D. Chief, Lymphoma Service Memorial Sloan-Ke=ering Cancer Center Thursday March 15, 2018: 10:15-10:30 am 1992 (Cell): Durkop
More informationClinical Advances in Lymphoma
Conflicts of Interest Clinical Advances in Lymphoma Alex F. Herrera, MD Assistant t Professor Department of Hematology and HCT City of Hope BMS research funding (institutional), consultancy Genentech research
More informationOSCO/OU ASH-SABC Review. Lymphoma Update. Mohamad Cherry, MD
OSCO/OU ASH-SABC Review Lymphoma Update Mohamad Cherry, MD Outline Diffuse Large B Cell Lymphoma Double Hit Lymphoma Follicular and Indolent B Cell Lymphomas Mantle Cell Lymphoma T Cell Lymphoma Hodgkin
More informationROME BREAST SURGERY. June Crowne Plaza Rome St. Peter's
ROME BREAST SURGERY June 14 15 Crowne Plaza Rome St. Peter's 2 0 1 7 SCIENTIFIC COMMITTEE Roy de Vita, M.D. Chief of Plastic and Reconstructive Surgery Department at the National Cancer Institute of Rome
More informationCORSO DI AGGIORNAMENTO E.C.M.
CORSO DI AGGIORNAMENTO E.C.M. RAZIONALE HIV Medicine is an ever-changing field: what today seems to be up-to-the-minute treatment often tomorrow is already out of date! Progress continues to be particularly
More informationMastering the treatment of Depression and Schizophrenia
Florence January 17-18, 2017 Palazzo dei Congressi Piazza Adua, 1 Course Director: Andrea Fagiolini Mastering the treatment of Depression and Schizophrenia Advanced Psychopharmacology Course RATIONALE
More informationInnovative Strategies in Pediatric Oncology: for a Proactive Surgical and Clinical Approach
Innovative Strategies in Pediatric Oncology: for a Proactive Surgical and Clinical Approach Bologna (Italy), November 12 th 14 th, 2009 Organized by CHIRURGIA PEDIATRICA, UNIVERSITY OF BOLOGNA ONCOLOGIA
More informationNCCN Guidelines for B-Cell Lymphomas V Update Meeting 08/14/18
DIAG-1 Submission request from Adaptive Biotechnologies to add NGS as an additional option to PCR for assessing IGH and TCR gene rearrangements under Essential Diagnosis: (immunohistochemistry, flow cytometry,
More information9-10 November Nice, France
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Practice teaching course in head and neck cancer: focus on comprehensive management 9-10 November 2016 - Practice teaching course in head and neck cancer:
More informationJuly 5th-6th 2012 Faculty of Medicine University of Barcelona 2012 GREAT V INTERNATIONAL MEETING PROGRAMME
July 5th-6th 2012 Faculty of Medicine University of Barcelona 2012 GREAT V INTERNATIONAL MEETING PROGRAMME GREAT Scientific Committee Alexandre Mebazaa Salvatore Di Somma Christian Mueller GREAT V International
More informationFOLLICULAR LYMPHOMA: US vs. Europe: different approach on first relapse setting?
Indolent Lymphoma Workshop Bologna, Royal Hotel Carlton May 2017 FOLLICULAR LYMPHOMA: US vs. Europe: different approach on first relapse setting? Armando López-Guillermo Department of Hematology, Hospital
More information2018 KSMO Immune Oncology Forum. Immune checkpoint inhibitors in hematologic. malignancies: evidences and perspectives 서울아산병원종양내과 홍정용
2018 KSMO Immune Oncology Forum Immune checkpoint inhibitors in hematologic malignancies: evidences and perspectives 서울아산병원종양내과 홍정용 2018-07-18 Contents Introduction Immune checkpoint inhibtors in lymphomas
More informationRADIOIMMUNOTHERAPY FOR TREATMENT OF NON- HODGKIN S LYMPHOMA
RADIOIMMUNOTHERAPY FOR TREATMENT OF NON- HODGKIN S LYMPHOMA Pier Luigi Zinzani Institute of Hematology and Medical Oncology L. e A. Seràgnoli University of Bologna, Italy Slovenia, October 5 2007 Zevalin
More informationpulmonary hypertension bologna 2013 QUESTIONS, RECENT TRIALS, DEBATES AND CLINICAL CASES November 22-23, 2013 Royal Hotel Carlton - Bologna - Italy
Under the aegis of alma mater studiorum università di bologna pulmonary hypertension bologna 2013 QUESTIONS, RECENT TRIALS, DEBATES AND CLINICAL CASES Royal Hotel Carlton - - Italy November 22-23, 2013
More informationMANTLE CELL LYMPHOMA MTOR-INHIBITION
MANTLE CELL LYMPHOMA MTOR-INHIBITION Rome, 23. March 2017 Prof. Dr. med. Georg Heß III. Med. Klinik Universitäres Centrum für Tumorerkrankungen Universitätsmedizin der Johannes Gutenberg-Universität Mainz
More informationThis meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
More informationCheckpoint Inhibition in Hodgkin s Lymphoma John Kuruvilla, MD & Rob Laister, PhD
Checkpoint Inhibition in Hodgkin s Lymphoma John Kuruvilla, MD & Rob Laister, PhD Disclosures for Rob Laister Research Support Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific
More information13th Residential Course on Clinical Pharmacology of Antiretrovirals. Turin, January 2018
13th Residential Course on Clinical Pharmacology of Antiretrovirals Turin, 17-19 January 2018 NOTES 13th Residential Course on Clinical Pharmacology of Antiretrovirals Turin, 17-19 January 2018 COURSE
More informationInternational Conference on Malignant Lymphoma (ICML) June 14-17, 2017
International Conference on Malignant Lymphoma (ICML) June 14-17, 2017 INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR: CLINICAL ACTIVITY AND FAVORABLE SAFETY IN PATIENTS
More informationFondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Practice teaching course in head and neck cancer, 2-4 March 2016 - Overview Head and neck cancer treatment requires multidisciplinary cooperation between
More informationBabis Andreadis, MD, MSCE Associate Professor of Medicine UCSF. Outline
ANCO Update in Lymphomas 2017 Babis Andreadis, MD, MSCE Associate Professor of Medicine UCSF Outline DLBCL Incorporating biomarkers in treatment choice CART19 therapy is here Mantle Cell Lymphoma: Induction
More informationHONORARY PRESIDENT: GIUSEPPE LEONE CONGRESS ORGANIZERS: FRANCESCO LO COCO, LIVIO PAGANO, MARIA TERESA VOSO. Program
HONORARY PRESIDENT: GIUSEPPE LEONE CONGRESS ORGANIZERS: FRANCESCO LO COCO, LIVIO PAGANO, MARIA TERESA VOSO Program Dear Colleague, we are pleased to welcome you to the 5 th International Symposium on Secondary
More informationDiffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma (DLBCL) DLBCL/MCL Dr. Anthea Peters, MD, FRCPC University of Alberta/Cross Cancer Institute Disclosures Honoraria from Janssen, Abbvie, Roche, Lundbeck, Seattle Genetics Objectives
More informationRelapsed/Refractory Hodgkin Lymphoma
Relapsed/Refractory Hodgkin Lymphoma Anas Younes, MD Chief, Lymphoma Service Memorial Sloan-Kettering Cancer Center New York, New York, United States Case Study 32-year-old woman was diagnosed with stage
More informationPanel Discussion/References
Follicular Lymphoma (FOLL) Panel discussion to reassess the category designation for lenalidomide + rituximab as a firstline therapy for FL. Panel discussion to reassess the inclusion of radioimmunotherapy
More informationFrankfurt, January
Frankfurt, January 12-13 2018 Frankfurt, January 12-13 2018 SMART ORGANIZING AND SCIENTIFIC COMMITTEE M. Antonelli, G. Bellani, A. Braschi, G. Conti, L. Gattinoni, A. Pesenti, M. Quintel, F. Raimondi,
More informationA CME-certified Oncology Exchange Program
A CME-certified Oncology Exchange Program Jointly provided by Potomac Center for Medical Education and Rockpointe Supported by an educational grant from Seattle Genetics, Inc. Re-treatment with BV Bartlett
More informationM Trneny 5. C Joao 8 M Witzens-Harig 9. M Jerkeman 3. D Caballero 7. SRule 1. C Rusconi 4. W Jurczak 2. F Offner 6. I Bence-Bruckler 11.
Leukemia https://doi.org/10.1038/s41375-018-0023-2 BRIEF COMMUNICATION Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international,
More informationMathias J Rummel, MD, PhD
I N T E R V I E W Mathias J Rummel, MD, PhD Prof Rummel is Head of the Department of Hematology at the Hospital of the Justus-Liebig University in Gießen, Germany. Tracks 1-17 Track 1 Track 2 Track 3 Track
More informationOTC FOUNDATION LEADERSHIP FORUM
OTC FOUNDATION LEADERSHIP FORUM SALA PLENARIA MASCAGNI HOTEL LEON D ORO VERONA, 16 17 JUNE 2016 CO-CHAIRED BY JOERG FRANKE, PRESIDENT OTCF/GA GUIDO ROCCA, PRESIDENT OTC ITALY LIST OF FACULTY CO CHAIRMEN
More information6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.
MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe
More informationCheckpoint Blockade in Hematology and Stem Cell Transplantation
Checkpoint Blockade in Hematology and Stem Cell Transplantation Saad S. Kenderian, MD Assistant Professor of Medicine and Oncology Mayo Clinic College of Medicine October 14, 2016 2015 MFMER slide-1 Disclosures
More informationKIDNEY LIVER MEETS FINAL PROGRAM KIDNEY MEETS LIVER. When the excellence in renal and liver medicine come together. XXXXXXX
XXXXXXX When the excellence in renal and liver medicine come together. 1 COMITATI SCIENTIFIC PROGRAM Organizing Committee Prof. Michel Jadoul Chief Service de Nephrologie Clinique Universitaire Saint-Luc
More informationPCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE
PCHF POSTGRADUATE COURSE IN HEART FAILURE A novel course in heart failure management Certified by the European Society of Cardiology (ESC) and the University of Zurich. Based on the new curriculum of the
More information6 TH INTERNATIONAL TECHNO-UROLOGY MEETING (TUM) NEW TECHNOLOGIES FOR A MORE PRECISE SURGERY
Azienda Sanitaria Ospedaliera S.Luigi Gonzaga Orbassano (To) Department of Urology, San Luigi Gonzaga Hospital School of Medicine - University of Torino, Orbassano, Torino, Italy Chairmen: Prof. Francesco
More informationImmunotherapy in Hematological Malignancies 2018
1st Cuneo City Immunotherapy Conference (CCITC) Immunotherapy in Hematological Malignancies 2018 CUNEO May 17-19, 2018 Centro Incontri Organized by Prof. Massimo Massaia, SC Ematologia AO S. Croce e Carle,
More information8 th EULAR Course on Capillaroscopy in Rheumatic Diseases
8 th EULAR Course on Capillaroscopy in Rheumatic Diseases 13 th -15 th September, 2018 Genova, Italy eular.org ORGANISATION AND COMMITTEE Scientific Organiser Maurizio Cutolo, MD Director Research Laboratory
More informationThe Cardiometabolic Syndrome
Under the patronage of: University of Rome La Sapienza University of Rome Tor Vergata Fondazione Umberto Di Mario ONLUS SID - Società Italiana di Diabetologia SIE - Società Italiana di Endocrinologia SIIA
More informationClinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME
With an unrestricted grant by Organized by Vall d Hebron Barcelona Hospital Campus Barcelona, Spain International FINAL PROGRAMME Respiratory diseases are among the most frequent causes of mortality and
More informationPreliminary Programme Hotel du Lac, Ioannina, Greece (Congress Halls, Main Building) Educational Edition Greece 2014
Organized by: International Symposium Intra Articular Treatment National Foundation of Ultrasound Guided Hip Intra-Articular Therapy (ANTIAGE) www.antiagefbf.it In collaboration with: Rheumatology Clinic,
More information4TH INTERNATIONAL PATIENT AND PHYSICIAN SUMMIT ON WALDENSTROM S MACROGLOBULINEMIA MARCH 10-13, 2011, ORLANDO, FL, USA
4TH INTERNATIONAL PATIENT AND PHYSICIAN SUMMIT ON WALDENSTROM S MACROGLOBULINEMIA MARCH 10-13, 2011, ORLANDO, FL, USA Thursday, March 10, 2010 Buena Vista Palace Hotel 3:00 PM to 6:00 PM Registration (Hampton
More informationBrentuximab vedotin in Relapsed Primary Mediastinal Large B-Cell Lymphoma: Results from a Phase 2 Clinical Trial
Blood First Edition Paper, prepublished online March 6, 2017; DOI 10.1182/blood-2017-01-764258 Letter To Blood Brentuximab vedotin in Relapsed Primary Mediastinal Large B-Cell Lymphoma: Results from a
More information8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)
Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized
More informationCME Information LEARNING OBJECTIVES
CME Information LEARNING OBJECTIVES Assess the efficacy and safety of brentuximab vedotin in investigational settings, such as in combination with AVD for patients with newly diagnosed HL, as consolidation
More informationDIABETES AND MACROVASCULAR DISEASE
Second International Course on DIABETES AND MACROVASCULAR DISEASE Lugano (CH), March 27-29, 2003 Scientific Programme Thursday, March 27, 2003 15.45 16.00 Opening Remarks Session 1: DIABETES MELLITUS A
More informationIBUS MULTIMODALITY BREAST IMAGING AND IMAGE -GUIDED INTERVENTIONS COURSE
SCIENTIFIC PROGRAM Thursday, 6 th June 2019 09.00-09.10 Welcome and announcements G. Xepapadakis 09.10-09.20 Introduction D. Koufoudakis 09.20-09.40 IBUS achievements 09.40-10.00 Anatomy of the breast
More informationDERMATOLOGIC CARE IN ONCOLOGY
Is pleased to announce: Friday, October 23, 2015 FOURTH ANNUAL DERMATOLOGIC CARE IN ONCOLOGY SYMPOSIUM CONFERENCE LOCATION MEMORIAL SLOAN KETTERING CANCER CENTER ROCKEFELLER RESEARCH LABORATORIES BOARD
More informationAesculap Programme Expertise in Interlocking Nailing
Aesculap Programme Expertise in Interlocking Nailing Challenges and complications in complex fractures Aesculap Orthopaedics April 26-27, 2012 Krakow, Poland In cooperation with The most successful in
More informationDisclosures of XXXXX
Disclosures of XXXXX Company name Research support Employee Consultant Stockholder Speakers bureau Advisory board Other Abbvie X X Genentech X X Gilead X Bayer X X Incyte X Samus Therapeutics X BCL-2 Inhibitors
More informationWhat is the best second-line approach to induce remission prior to stem cell transplant? Single agent brentuximab vedotin
What is the best second-line approach to induce remission prior to stem cell transplant? Single agent brentuximab vedotin Alison Moskowitz, MD Assistant Attending, Lymphoma Service Memorial Sloan Kettering
More informationOVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
More information8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT]
8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT] Madrid, Spain Saturday, 8 th June Sunday, 9 th June 2019 1 ORGANISATION COMMITTEE Scientific Organisers Esperanza Naredo Ingrid Möller
More informationLymphoma John P. Leonard, M.D.
Lymphoma 2017 John P. Leonard, M.D. Richard T. Silver Distinguished Professor of Hematology and Medical Oncology Associate Dean for Clinical Research Vice Chairman, Department of Medicine Disclosures Consulting
More information17th. Endocrine Surgery. International Postgraduate Course in. Scientific Programme 31/5-2/6
International Postgraduate Course in Endocrine Surgery 31/5-2/6 www.endocrinesurgery.com Scientific Programme International Postgraduate Course in Endocrine Surgery Dear Colleagues, The International Postgraduate
More informationpan-canadian Oncology Drug Review Final Economic Guidance Report Ibrutinib (Imbruvica) for Mantle Cell Lymphoma July 19, 2016
pan-canadian Oncology Drug Review Final Economic Guidance Report Ibrutinib (Imbruvica) for Mantle Cell Lymphoma July 19, 2016 DISCLAIMER Not a Substitute for Professional Advice This report is primarily
More informationISHNOS November Pastoral Hotel, Israel. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology
The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology ISHNOS 2018 www.ishnos.com Conference Secretariat Umbrella Events E-mail: umbrella.inquiry@gmail.com www.umbrella-events.com
More informationTreatment Landscape in R/R DLBCL Novel Targets and Strategies. Wyndham H. Wilson, M.D., Ph.D. Senior Investigator
Treatment Landscape in R/R DLBCL Novel Targets and Strategies Wyndham H. Wilson, M.D., Ph.D. Senior Investigator Gene-expression profiling of DLBCL subtypes Roschewski, M. et al. (2013) Nat. Rev. Clin.
More informationLymphoma update: turning biology into cures. Peter Johnson
Lymphoma update: turning biology into cures Peter Johnson Selected highlights of recent research 1. Using FDG-PET to modify treatment and avoid long term toxicity in Hodgkin lymphoma 2. Understanding how
More informationBrentuximab Vedotin in Lymphomas
New Drugs In Hematology Brentuximab Vedotin in Lymphomas Anas Younes, M.D. Chief, Lymphoma Service Memorial Sloan-Kettering Cancer Center Monday, May 9, 2016 9:15-9:45 a.m U.S. Cancer Statistics 2016 300.000
More informationHypertension& CV Risk From Science To Practice
The Egyptian Hypertension Society The 14th Annual Scientific Meeting Hypertension& CV Risk From Science To Practice April 7-9, 2010 Fairmont Heliopolis Hotel Chairpersons of the Meeting Ahmed Magdy, MD,
More informationCURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS WITH DIABETES AND CVD
Associazione Chaira Medica This event is compliant with the Eucomed Code of Ethical Business Practice (www.ethicalmedtech.eu) 5 th Post-graduate Updating Course CURRENT STRATEGIES TO OPTIMALLY TREAT PATIENTS
More informationESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
More information